Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary artery disease: long-term results of the FAME 2 trial

Journal:
Nature Medicine
Published:
Affiliations:
30
Authors:
30
Institutions Authors Share
AZORG, Belgium
5.000000
0.17
University of Oxford, United Kingdom (UK)
3.000000
0.10
Catharina Hospital, Netherlands
2.500000
0.08
University Hospital of Lausanne (CHUV), UNIL, Switzerland
2.000000
0.07
Sapienza University of Rome, Italy
1.000000
0.03
Gottsegen National Cardiovascular Center, Hungary
1.000000
0.03
University of Kragujevac, Serbia
1.000000
0.03
Heart Center Leipzig, Germany
1.000000
0.03
Karolinska Institute (KI), Sweden
1.000000
0.03
University Hospital Brno, Czech Republic
1.000000
0.03
Atlanta VA Medical Center, United States of America (USA)
1.000000
0.03
Northern Light Health, United States of America (USA)
1.000000
0.03
University Hospital of Munich (KUM), LMU, Germany
1.000000
0.03
Na Homolce Hospital, Czech Republic
1.000000
0.03
Clinical Hospital Center Zemun, Serbia
1.000000
0.03
Arcispedale Sant'Anna, Italy
1.000000
0.03
Stanford University School of Medicine, United States of America (USA)
0.500000
0.02
VA Palo Alto Healthcare System (VAPAHCS), United States of America (USA)
0.500000
0.02
Showa Medical University, Japan
0.500000
0.02
Eindhoven University of Technology (TU/e), Netherlands
0.500000
0.02
Lyon University Hospital (HCL), France
0.500000
0.02
Claude Bernard University Lyon 1 (UCBL), France
0.500000
0.02
Rigshospitalet, Denmark
0.500000
0.02
University of Copenhagen (UCPH), Denmark
0.500000
0.02
Hachioji Medical Center, Tokyo Medical University, Japan
0.500000
0.02
Aarhus University Hospital, Denmark
0.400000
0.01
Örebro University Hospital (USÖ), Sweden
0.200000
0.01
Aarhus University (AU), Denmark
0.200000
0.01
Steno Diabetes Center Aarhus, Denmark
0.200000
0.01